Molecular Response to PARP1 Inhibition in Ovarian Cancer Cells as Determined by Mass Spectrometry Based Proteomics
A. Franz, F. Coscia, C. Shen, L. Charaoui, M. Mann, C. Sander
This study uses proteomics to analyze how ovarian cancer cells respond to PARP1 inhibition, identifying adaptive resistance mechanisms and potential therapeutic targets.
bioRxiv · Mar 12, 2021 · PreprintCancer Biology